Updated data from india's covaxin's final phase of trials shows that the vaccine can “neutralise” deadly mutations – including the double mutant. WION's Palki Sharma tells you more. An interim analysis of the final phase data.
Covaxin, bharat biotech, covid-19 vaccine, covid19 vaccine india